Advertisement

Topics

Actelion Pharmaceuticals US, Inc. Company Profile

22:52 EDT 21st September 2017 | BioPortfolio

Actelion Ltd is a biopharmaceutical company with its corporate headquarters in Allschwil/Basel, Switzerland. Actelion's first drug Tracleer® (bosentan), an orally available dual endothelin receptor antagonist, has been approved as a therapy for pulmonary arterial hypertension. Actelion markets Tracleer® through its own subsidiaries in key markets worldwide, including the United States (based in South San Francisco), the European Union, Japan, Canada, Australia and Switzerland. Actelion, founded in late 1997, is a leading player in innovative science related to the endothelium - the single layer of cells separating every blood vessel from the blood stream. Actelion's over 2000 employees focus on the discovery, development and marketing of innovative drugs for significant unmet medical needs. Actelion shares are traded on the SIX Swiss Exchange (ticker symbol: ATLN) as part of the Swiss blue-chip index SMI (Swiss Market Index SMI®).


News Articles [1335 Associated News Articles listed on BioPortfolio]

Idorsia gets share of ponesimod and cadazolid revenues from Actelion

Idorsia Pharmaceuticals Ltd. entered a revenue sharing agreement with Actelion Pharmaceuticals Ltd., from which it spun off earlier this year. The arrangement relates to Actelion's ponesimod and cadaz...

Actelion Pharmaceuticals Ltd: Actelion provides an update on the Phase III IMPACT program with cadazolid in CDAD

Actelion Pharmaceuticals Ltd / Actelion provides an update on the Phase III IMPACT program with cadazolid in CDAD . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely res...

Actelion Pharmaceuticals Ltd: Actelion veröffentlicht Update zum Phase-III-Programm IMPACT mit Cadazolid bei CDAD

Actelion Pharmaceuticals Ltd / Actelion veröffentlicht Update zum Phase-III-Programm IMPACT mit Cadazolid bei CDAD . Verarbeitet und übermittelt durch Nasdaq Corporate Solutions. Für den Inhalt der...

Actelion Pharmaceuticals Ltd: Actelion announces changes to its executive team upon completion of the transaction with Johnson & Johnson

Actelion Pharmaceuticals Ltd / Actelion announces changes to its executive team upon completion of the transaction with Johnson & Johnson . Verarbeitet und übermittelt durch Nasdaq Corporate Soluti.....

Actelion Pharmaceuticals Ltd: Johnson & Johnson announces expected settlement of Actelion tender offer on June 16, 2017

Actelion Pharmaceuticals Ltd / Johnson & Johnson announces expected settlement of Actelion tender offer on June 16, 2017 . Verarbeitet und übermittelt durch Nasdaq Corporate Solutions. Für den Inha....

Actelion’s CEO Clozel Talks Prospects of his Spin-Off Idorsia

Actelion’s spin-off Idorsia is off to a great start with a large pipeline and full pockets. CEO Jean-Paul Clozel wants it to be a second Actelion. This January, Actelion, the largest biotech in ...

J&J completes Actelion acquisition for $30bn

Johnson & Johnson (J&J) has completed the acquisition of Actelion Pharmaceuticals for approximately $30bn in an all-cash transaction through its Swiss subsidiary Janssen Holding.

Appointments: Eli Lilly, Alexion, Actelion, Polyphor, Constellation, Bone Therapeutics and Allied Minds

This week's roundup includes the announced retirement of Lilly's CFO, high-level appointments by Alexion Pharmaceuticals, Actelion and Constellation, and board...   

Drugs and Medications [272 Associated Drugs and Medications listed on BioPortfolio]

Ventavis [Actelion Pharmaceuticals US, Inc.]

These highlights do not include all the information needed to use VENTAVIS safely and effectively. See full prescribing information for VENTAVIS. VENTAVIS (iloprost) inhalation solution Initial U.S. A...

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Veletri [Actelion Pharmaceuticals US, Inc.]

These highlights do not include all the information needed to use VELETRI safely and effectively. See full prescribing information for VELETRI. VELETRI (epoprostenol) for Injection Initial U.S. Approv...

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

PubMed Articles [156 Associated PubMed Articles listed on BioPortfolio]

Billion-dollar deals end eras of Ariad and Actelion.

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Comparative study on pharmaceuticals adsorption in reclaimed water desalination concentrate using biochar: Impact of salts and organic matter.

The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...

Clinical Trials [200 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [1282 Associated Companies listed on BioPortfolio]

Actelion Pharmaceuticals Ltd

Actelion aims to discover or in-license and develop a steady stream of new products as revenue sources, based on first-in class small molecule compounds. In doing so, Actelion is focussing on innovati...

Actelion Pharmaceuticals US, Inc.

Actelion Ltd is a biopharmaceutical company with its corporate headquarters in Allschwil/Basel, Switzerland. Actelion's first drug Tracleer® (bosentan), an orally available dual endothelin receptor a...

Actelion

Actelion Ltd, a biopharmaceutical company headquartered in Allschwil / Basel, Switzerland, is a leading player in innovative science related to the endothelium - the single layer of cells separating e...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

More Information about "Actelion Pharmaceuticals US, Inc." on BioPortfolio

We have published hundreds of Actelion Pharmaceuticals US, Inc. news stories on BioPortfolio along with dozens of Actelion Pharmaceuticals US, Inc. Clinical Trials and PubMed Articles about Actelion Pharmaceuticals US, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Actelion Pharmaceuticals US, Inc. Companies in our database. You can also find out about relevant Actelion Pharmaceuticals US, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record